awmsg logo



miglustat (Zavesca®)


Reference No. 1577

Publication date:
27/07/2012


Appraisal information

miglustat (Zavesca®) 100 mg capsule


Company: Actelion Pharmaceuticals UK Ltd
BNF category: Nutrition and blood
NMG meeting date: Not scheduled
AWMSG meeting date: Not scheduled
   
   
Submission Type: Nonsubmission
Status: Not endorsed
Advice No: Not available
Ratification by Welsh Government: 23/07/2012

Current Progress


Submission
received
NMG
meeting
AWMSG
meeting
Ratification by
Welsh Government

AWMSG advice

In the absence of a submission from the holder of the marketing authorisation, miglustat (Zavesca®) cannot be endorsed for use within NHS Wales for the oral treatment of adult patients with mild to moderate type 1 Gaucher disease.
Statement of Advice (SOA)
Download